Pitcairn CO Boston Scientific Corp Transaction History

Pitcairn CO

$1.67 Billion
Q3 2024

A detailed history of Pitcairn CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Pitcairn CO holds 20,648 shares of BSX stock, worth $1.87 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

20,648

Previous 18,069 14.27%

Holding current value

$1.87 Million

Previous $1.39 Million 24.37%

% of portfolio

0.1%

Previous 0.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$72.96 - $84.0 $188,163 - $216,636	2,579 Added 14.27%	20,648 $1.73 Million
Q2 2024 Aug 13, 2024	BUY	$67.33 - $77.71 $771,601 - $890,556	11,460 Added 173.4%	18,069 $1.39 Million
Q1 2024 May 13, 2024	SELL	$57.6 - $68.62 $23,558 - $28,065	-409 Reduced 5.83%	6,609 $452,000
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $2,772 - $3,295	-57 Reduced 0.81%	7,018 $405,000
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $36,488 - $39,752	727 Added 11.45%	7,075 $373,000
Q2 2023 Aug 11, 2023	BUY	$49.72 - $54.64 $4,474 - $4,917	90 Added 1.44%	6,348 $343,000
Q1 2023 May 05, 2023	BUY	$45.09 - $50.03 $60,420 - $67,040	1,340 Added 27.25%	6,258 $313,000
Q4 2022 Feb 13, 2023	BUY	$39.56 - $47.22 $194,556 - $232,227	4,918 New	4,918 $227,000
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $166,473 - $222,500	-4,724 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$40.9 - $45.1 $193,211 - $213,052	4,724 New	4,724 $209,000
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $179,500 - $211,562	-4,715 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$41.23 - $45.88 $1,319 - $1,468	32 Added 0.68%	4,715 $205,000
Q2 2021 Aug 11, 2021	BUY	$38.58 - $44.24 $180,670 - $207,175	4,683 New	4,683 $200,000

Others Institutions Holding BSX

# of Institutions

1,543

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account